FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19

NewsColony
FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19

(AP) — U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

The drug is given as a one-time treatment through an IV. The FDA allowed its use in adults and children 12 and over who weigh at least 88 pounds (40 kilograms) and who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

Emergency authorization allows use of the drug to start while studies are continuing to establish safety and effectiveness. Early results suggest the drug may reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression, the FDA said.

Regeneron said that initial doses will be made available to roughly 300,000 patients through a federal government allocation program. Patients will not be charged for the drug but may have to pay part of the cost of giving the IV.

Initial supplies will likely be vastly outstripped by demand as the U.S. has surged past 10 million reported cases, with the country facing what health experts say will be a dark winter due uncontrolled spread of the virus.

Antibodies are proteins the body makes to target and help eliminate viruses, but it can take weeks for the best ones to form after an infection occurs. The drugs are concentrated versions of ones that proved best able to do this in lab and animal tests, and in theory help the body start to fight the virus right away.

The Regeneron drug is a combo of two antibodies to enhance the chances it will prove effective. Earlier this month, the FDA gave emergency authorization to a single-antibody drug from Eli Lilly that also is still being studied.

There’s no way to know whether the Regeneron drug helped Trump recover; he received a host of treatments and most COVID-19 patients recover on their own.

FDA regulators authorized the Regeneron drug using their emergency powers to quickly speed the availability of experimental drugs and other medical products during public health crises.

In normal times the FDA requires “substantial evidence” to show that a drug is safe and effective, usually through one or more large, rigorously controlled patient studies. But during public health emergencies the agency can lower those standards and require only that an experimental treatment’s potential benefits outweigh its risks.

The emergency authorization functions like a temporary approval for the duration of the COVID-19 pandemic. To win full approval, Regeneron will have to submit additional research to fully define the drug’s safety and benefit for patients.

Also From CBS Chicago:

Source: CBS Chicago | News Colony

The post FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19 appeared first on NewsColony.
NewsColony

source https://newscolony.com/fda-allows-emergency-use-of-regeneron-antibody-drug-trump-received-for-covid-19/

Volunteers book hotel room for homeless man with SingapoRediscovers vouchers

NewsColony Volunteers book hotel room for homeless man with SingapoRediscovers vouchers © The Independent Singapore Singapore — A group of volunteers from the Mummy Yummy Singapore welfare organisation donated their SingapoRediscovers Vouchers to book a hotel room for a homeless man. The man, who was identified as Jayden, did not have a place to live while waiting for the Housing Board (HDB) to allocate him a rental flat. In a Facebook post on Mummy Yummy Singapore’s page on Wednesday (Dec 16), the volunteers said: “We used our $100 Rediscover Singapore vouchers to redeem hotel stay for him and successfully booked 9 days worth of stay at 3 days per voucher.” They added that they were unable to book a longer stay because of higher hotel rates over Christmas and New Year. The volunteers hoped that they would be able to bridge Jayden’s stay until he got a flat. “Thanks our government for giving us these vouchers which in return we can put them to good use for people in need,” th...

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs NewsColony Perhaps it’s appropriate that public notices of the COVID-19 crisis began as an ableist cruelty. Health officials assured the nation that only the elderly and those with chronic health conditions would be seriously affected; most Americans (i.e., the normal people) would have only mild symptoms and be fine. x A friendly reminder: people who will be high-risk patients if we get coronavirus can hear you when you reassure everyone we’re the only ones who might die. Ã¢Â€Â” Alexandra Brodsky (@azbrodsky) February 29, 2020 Soon after the announcement of those assurances, the likelihood of high-risk people surviving was further limited by the people more likely to be fine. Shopping frenzies cleared stores of essential supplies needed everyday by many disabled people, like thermometers, hand wipes, masks, and IV infusion supplies. Accustomed to their needs ...

Coronavirus UK: BBC makes changes to ‘lift people’s spirits’

Coronavirus UK: BBC makes changes to ‘lift people’s spirits’ NewsColony BBC viewers have been warned that ‘things will look and sound a bit different’ during the coronavirus crisis. In a blog post on the corporation’s website, BBC News Chief Fran Unsworth outlined a number of changes its newsroom was making in light of the ‘rapidly evolving situation’. Among the changes, presenters will doing their own make-up, many interviews will be conducted remotely and the BBC will rely more on its network of local reporters, Ms Unsworth explained. TV veterans Mr Motivator and Angela Rippon have also signed up for a new BBC One show to lift people’s spirits during the pandemic. HealthCheck UK Live, with Watchdog’s Michelle Ackerley and CBBC star Dr Xand van Tulleken will air every weekday for two weeks. TV veterans Mr Motivator and Angela Rippon have also signed up for a new BBC One show to lift people’s spirits during the pandemic HealthCheck UK Live, with Wa...

NewsColony

Search This Blog